首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >Defining IgA1 O-glycan Heterogeneity by use of ECD and IgA Specific Proteases
【24h】

Defining IgA1 O-glycan Heterogeneity by use of ECD and IgA Specific Proteases

机译:通过使用ECD和IgA特异性蛋白酶定义IgA1 O-聚糖的异质性

获取原文

摘要

The combination of bacterial IgA specific proteases and AI-ECD/ETD fragmentation provides complete site localization of the 5 most abundant IgA1 O-glycoforms. Each IgA1 HR fragment O-glycoform produces a unique set of ECD/ETD type fragments that appear to be charge state dependent. Complete analysis of O-glycoform microheterogeneity and site-localization can be accomplished with less than 3 (mu)g of isolated IgA1. This provides the opportunity to analyze the low abundance pathogenic forms of IgA1 that lead to the formation of circulating immune complexes and deposition of IgA1 in the kidney of IgAN patients. Analysis of clinical samples will be possible with standard collection amounts of serum from patients with IgA nephropathy. ECD analysis of the variety of IgA1 HR proteolytic fragments provides a practical set of guidelines for the analysis of clustered sites of O-glycosylation.
机译:细菌IgA特异性蛋白酶和AI-ECD / ETD碎片的组合提供了5个最丰富的IGA1 O-糖族的完全位点定位。每个IgA1 HR片段O-Glycoform产生一组独特的ECD / ETD型片段,似乎是充电状态的依赖性。完全分析O-Glycoform微孔和位点定位可以用小于3(mu)g的分离的IgA1来完成。这提供了分析IGA1的低丰度致病形式的机会,导致循环免疫复合物的形成和IgA1在IgAN患者的肾脏中的沉积。临床样品的分析将可能与IgA肾病患者的标准收集量的血清。各种IGA1 HR蛋白水解片段的ECD分析提供了一种实用的o-糖基化聚集位点的指导方针。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号